Literature DB >> 14714852

Interaction of thioridazine with ocular melanin in vitro.

Ewa Buszman1, Renata Rózańska.   

Abstract

The aim of this study was to examine in vitro the binding capacity of thioridazine to natural melanin isolated from pig eyes and to synthetic DOPA-melanin. The amount of drug bound to melanin was determined by the use of the UV spectrophotometric method. Studies on the kinetics of thioridazine-melanin complex formation showed that the amount of drug bound to melanin increases with increasing initial drug concentration and the prolongation or incubation time, allowed to attain equilibrium state after about 24 hours. Binding parameters, i.e., the number of independent binding sites and the association constants were determined on the basis of Scatchard plots. For thioridazine-ocular melanin and thioridazine-DOPA-melanin complexes two classes of binding sites were found with the association constants K1 approximately 2 x 10(4) M(-1) and K2 approximately 9 x 10(2) M(-1). For ocular and synthetic melanin complexes with thioridazine no significant differences in the values of binding parameters were found. The demonstrated ability of thioridazine to interact with melanin in vitro is discussed in relation to this drug ocular toxicity in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14714852

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  3 in total

Review 1.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 2.  Melanin, the What, the Why and the How: An Introductory Review for Materials Scientists Interested in Flexible and Versatile Polymers.

Authors:  A Bernardus Mostert
Journal:  Polymers (Basel)       Date:  2021-05-20       Impact factor: 4.329

3.  Descemet's Stripping-automated Endothelial Keratoplasty for symptomatic thioridazine deposits in the cornea.

Authors:  Masoumeh Mohebbi; Hassan Hashemi; Alireza Mahmoudi; Pasha Anvari
Journal:  Taiwan J Ophthalmol       Date:  2017 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.